Generic Names of Some Trade Name Drugs, THE MERCK MANUAL OF HEALTH & AGING Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs -~ Generic Names of Some Trade Name Drugs - Generic Names of Some...
Some Trade Names of Generic Drugs, THE MERCK MANUAL OF HEALTH & AGING Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs-~ Generic Names of Some Trade Name Drugs - Some Trade Names of...
THE MERCK MANUAL OF GERIATRICS, App. III, Trade Names of Some Commonly Used Drugs, ABBOKINASE to BUTAZOLIDIN Trade Names of Some Commonly Used Drugs TRADE AND GENERIC NAMES OF COMMONLY USED DRUGS ABBOKINASE to BUTAZOLIDIN Trade Name Generic ABBOKINASE Urokinase ACCOLATE Zafirlukast ACCUPRIL Quinapril ACCUTANE Isotretinoin ACHROM YCIN V Tetracycline ACTHAR Corticotropin (ACTH) ACTIFED *Triprolidine ADALAT Nifedipine ADENOCARD Adenosine ADRIAMYCIN Doxorubicin ADVIL Ibuprofen...
THE MERCK MANUAL OF GERIATRICS, App. III, Trade Names of Some Commonly Used Drugs. Salmeterol to Zolpidem Trade Names of Some Commonly Used Drugs GENERIC AND TRADE NAMES OF COMMONLY USED DRUGS Salmeterol to Zolpidem Generic Trade Name Salmeterol SEREVENT Salsalate DISALCID, SALFLEX Saquinavir FORTOVASE Sargramostim LEUKINE Secobarbital SECONAL Selegiline ELDEPRYL Selenium SELSUN Sertraline ZOLOFT Sibutramine MERIDIA Sildenafil VIAGRA Silver sulfadiazine SILVADENE Simethicone MYLICON...
Fonds de Decouvertes Medicales Canadiennes Inc. Valeur de l'actif net en date du 04/16/04: $9.94 Microbix Signs Major License Agreement For Urokinase (19 novembre 2002) Microbix Biosystems IncAbbokinase is forecast to reach US$360 million by 2005 according to a May 16, 2002 report published by J.P
Therapeutic Biological Approvals FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER - Search - -Therapeutic Biological Approvals - Tradename/ Proper Name Indication for Use STN Manufacturer/ License NoAbbokinase Urokinase For adults for the lysis of acute massive pulmonary emboli, defined as obstruction of blood flow to a lobe or multiple segments, and...
Documents Available from the Center for Biologics Evaluation and Research page 36
author: CBER FDA
Documents Available from the Center for Biologics Evaluation and Research page 35
author: CBER FDA
THE MERCK MANUAL OF GERIATRICS, App. III, Trade Names of Some Commonly Used Drugs, ABBOKINASE to BUTAZOLIDIN Trade Names of Some Commonly Used Drugs TRADE AND GENERIC NAMES OF COMMONLY USED DRUGS ABBOKINASE to BUTAZOLIDIN Trade Name Generic ABBOKINASE Urokinase ACCOLATE Zafirlukast ACCUPRIL Quinapril ACCUTANE Isotretinoin ACHROMYCIN V Tetracycline ACTHAR Corticotropin (ACTH) ACTIFED *Triprolidine ADALAT Nifedipine ADENOCARD Adenosine ADRIAMYCIN Doxorubicin ADVIL Ibuprofen...
THE MERCK MANUAL OF GERIATRICS, App. III, Trade Names of Some Commonly Used Drugs. Salmeterol to Zolpidem Trade Names of Some Commonly Used Drugs GENERIC AND TRADE NAMES OF COMMONLY USED DRUGS Salmeterol to Zolpidem Generic Trade Name Salmeterol SEREVENT Salsalate DISALCID, SALFLEX Saquinavir FORTOVASE Sargramostim LEUKINE Secobarbital SECONAL Selegiline ELDEPRYL Selenium SELSUN Sertraline ZOLOFT Sibutramine MERIDIA Sildenafil VIAGRA Silver sulfadiazine SILVADENE Simethicone MYLICON...
DRUG PRODUCTS WITH APPROVAL UNDER SECTION 505 OF THE ACT Food and Drug Administration • Center for Drug Evaluation and Research Approved Drug Products Search DRUG PRODUCTS WITH APPROVAL UNDER SECTION 505 OF THE ACT ADMINISTERED BY THE CENTER FOR BIOLOGICS EVALUATION AND RESEARCH LIST ANTICOAGULANT CITRATE DEXTROSE SOLUTION (ACD) INJECTABLE; INJECTION ACD-A SOLUTION GAMBRO BCT, INC ANDA N010228 FEB 25, 2002 - ANTICOAGULANT CITRATE...
author: USERNAME
Important Drug Warning: Safety Information Regarding the use of Abbokinase (Urokinase) FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER - Search - -Important Drug Warning: Safety Information Regarding the use of Abbokinase (Urokinase) Public Health Service Food and Drug Administration 1401 Rockville Pike Rockville, MD 20852-1448 January 25, 1999 IMPORTANT DRUG WARNING Dear Healthcare Provider: The purpose of this letter is...
Update on Abbokinase (Urokinase) FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER - Search - - Update on Abbokinase (Urokinase) March 16, 1999 FDA is receiving new inquiries regarding a reported shortage of Abbokinase (Urokinase), a thrombolytic product manufactured by Abbott Laboratories (Abbott)
Update on Abbokinase (Urokinase) FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER - Search - -Update on Abbokinase (Urokinase) March 22, 1999 After FDA updated the Information Sheet on Abbokinase (Urokinase) on March 16, 1999, Abbott Laboratories sent a -Dear Abbokinase Customer- message by Western Union Mailgram that evening
Dear Colleague Letter - Abbott Laboratories Manufacturing Deficiencies with Abbokinase Parkinson: The Food and Drug Administration (FDA) conducted inspections of Abbott Laboratories facility at 1401 Sheridan Road, North Chicago, Illinois between October 22 and November 10, 1998 (water for injection) and October 26 and November 20, l998 (Abbokinase -Urokinase)
CBER - Urokinase (Abbokinase), Abbott Laboratories FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER - Search - -Product Approval Information - New Drug Application Product name: Urokinase (Abbokinase) Manufacturer: Abbott Laboratories, Abbott Park, IL Intended Use: for adults for the lysis of acute massive pulmonary emboli, defined as obstruction of blood flow to a lobe or multiple...
Letters to Industry / Healthcare Providers / Clinical Investigators FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER - Search - -Letters to Industry / Healthcare Providers / Clinical Investigators Therapeutic Biological Products Letter to Abbott Laboratories Concerning Serious Manufacturing Deficiencies with Abbokinase -7/14/1999 (PDF) , (Text) Serious Manufacturing Deficiencies with Abbokinase Prompt FDA...
Abbokinase (Urokinase) -Package Insert FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER Package Insert Abbokinase (Urokinase) Abbott Laboratories - Table of Contents Description Clinical Pharmacology Indications and Usage Contraindications Warnings Precautions Adverse Reactions Dosage and Administration How Supplied DESCRIPTION Abbokinase® (urokinase) is a thrombolytic...
http://www.fda.gov/cder/foi/label/2002/urokabb101002LB.pdf 1 Abbokinase ® UROKINASE DESCRIPTION Abbokinase ® (urokinase) is a thrombolytic agent obtained from human neonatal kidney cells grown in tissue cultureAbbokinase ® (IU) Number of Vials of Abbokinase ® Volume of Abbokinase ® After Reconstitution ...
http://www.fda.gov/cder/foi/label/2002/urokabb101002LB.pdf page 9
http://www.fda.gov/cder/foi/label/2002/urokabb101002LB.pdf page 2
http://www.fda.gov/cder/foi/label/2002/urokabb101002LB.pdf page 1
Issued: 01-25-1999 Important Drug Warning Safety Info Urokinase (Abbokinase) ** 3 I DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service 2 !i 5 I % G 4 %,,, 'I Food and Drug Administration 1401 Rockville Pike Rockville, MD 20852- 1448 January 25, 1999 IMPORTANT DRUG WARNING Dear Healthcare Provider: The purpose of this letter is to inform you of important safety information regarding the use of Abbokinase (Urokinase)
author: CBER FDA
subject: Safety Info Urokinase (Abbokinase)
Issued: 01-25-1999 Important Drug Warning Safety Info Urokinase (Abbokinase) page 2
author: CBER FDA
subject: Safety Info Urokinase (Abbokinase)
Issued: 01-25-1999 Important Drug Warning Safety Info Urokinase (Abbokinase) page 1
author: CBER FDA
subject: Safety Info Urokinase (Abbokinase)
